This is a preview of subscription content, log in via an institution to check access.
Reference
Micieli A, et al. Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage. Stroke : STROKEAHA120031108, Mar 2021. Available from: URL: http://doi.org/10.1161/STROKEAHA.120.031108
Rights and permissions
About this article
Cite this article
Andexanet "low value" for reversal of factor Xa-associated intracranial haemorrhage. PharmacoEcon Outcomes News 874, 5 (2021). https://doi.org/10.1007/s40274-021-7548-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7548-8